Protective effect of tanshinone IIA on the brain and its therapeutic time window in rat models of cerebral Ischemia-Reperfusion

Experimental and Therapeutic Medicine

Volumn 8, Issue 5, 2014, Pages 1616-1622

  Tang, Qiqiang ^a   Han, Ruodong ^a   Xiao, Han ^a   Li, Jun ^a   Shen, Jilong ^a   Luo, Qingli ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Middle cerebral artery occlusion; Neuroprotection; Tanshinone; Time window

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TANSHINONE IIA; THIOREDOXIN; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; COGNITION; DRUG MECHANISM; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; WESTERN BLOTTING;

EID: 84907819421     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1936     Document Type: Article

References (36)

1. Chollet F, Cramer SC, Stinear C,et al:Pharmacological therapies in post stroke recovery: recommendations for future clinical trials.J Neurol. (Epub ahead of print) 2013.
2. Candelario-Jalil E: Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 10: 644-654, 2009.
3. Lo EH, Dalkara T and Moskowitz MA: Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415, 2003.
4. Mustacich D and Powis G: Thioredoxin reductase. Biochem J 346 Pt 1: 1-8, 2000.
5. Kishimoto K, Li RC, Zhang J, et al: Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice. J Neuroinflammation 7: 42, 2010.
6. Stoyanova II and Lazarov NE: Localization of nitric oxide synthase in rat trigeminal primary afferent neurons using NADPH-diaphorase histochemistry. J Mol Histol 36:187-193, 2005.
7. Bredt DS and Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030-9033, 1989.
8. Kawase M, Kinouchi H, Kato I, et al: Inducible nitric oxide synthase following hypoxia in rat cultured glial cells. Brain Res 738: 319-322, 1996.
9. Hirota K, Nakamura H, Masutani H and Yodoi J: Thioredoxin superfamily and thioredoxin-inducing agents. Ann N Y Acad Sci 957: 189-199, 2002.
10. Berk BC: Novel approaches to treat oxidative stress and cardiovascular diseases. Trans Am Clin Climatol Assoc 118: 209-214, 2007.
11. Billiet L, Furman C, Cuaz-Pérolin C, et al: Thioredoxin-1 and its natural inhibitor, vitamin D3 up-regulated protein 1, are differentially regulated by PPARalpha in human macrophages. J Mol Biol 384: 564-576, 2008.
12. Watson HW, Yang X, Choi YE, Jones DP and Kehrer JP: Thioredoxin and its role in toxicology. Toxicol Sci 78: 3-14, 2004.
13. Xu W, Yang J and Wu LM: Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie 64: 332-336, 2009.
14. Lam BY, Lo AC, Sun X, Luo HW, Chung SK and Sucher NJ: Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10: 286-291, 2003.
15. Dong K, Xu W, Yang J, Qiao H and Wu L: Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice. Phytother Res 23: 608-613, 2009.
16. Adams JD, Wang R, Yang J and Lien EJ: Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin Med 1: 3, 2006.
17. Liu LL, Zhang XL, Wang L, et al: The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke. Brain Res Bull 82: 228-233, 2010.
18. Chen X, Zhou ZW, Xue CC, Li XX and Zhou SF: Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrier. Xenobiotica 37: 635-678, 2007.
19. National Research Council. Guide for the care and use of laboratory animals. 8th edition. The National Academies Press, Washington, DC, pp 1-246, 2001.
20. Engel O, Kolodziej S, Dirnagl U and Prinz V: Modeling stroke in mice -middle cerebral artery occlusion with the filament model. J Vis Exp 47: e2423, 2011.
21. Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989.
22. Hoffman GE, Merchenthaler I and Zup SL: Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 29: 217-231, 2006.
23. Wang LN, Zhang XJ, Liu LL, et al: Tanshinone IIA down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia. Brain Res 1321: 143-151, 2010.
24. Tang C, Xue HL, Bai CL, Fu R and Wu AH: The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine 17: 1145-1149, 2010.
25. Chen D, Tang J, Khatibi NH, et al: Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats. J Pharmacol Exp Ther 337: 663-672, 2011.
26. Cavallucci V and D'Amelio M: Matter of life and death: the pharmacological approaches targeting apoposis in brain diseases. Curr Pharm Des 17: 215-229, 2011.
27. Nizamutdinova IT, Jin YC, Kim JS, et al: Paeonol and paeoniflorin, the main active principles of Paeonia albiflora, protect the heart from myocardial ischemia/reperfusion injury in rats. Planta Med 74: 14-18, 2008.
28. Liu Y, Wang L, Li X, Lv C, Feng D and Luo Z: Tanshinone IIA improves impaired nerve functions in experimental diabetic rats. Biochem Biophys Res Commun 399: 49-54, 2010.
29. Zhang WJ, Feng J, Zhou R, et al: Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury. Eur J Pharmacol 648: 146-152, 2010.
30. Anctil M, Poulain I and Pelletier C: Nitric oxide modulates peristaltic muscle activity associated with fluid circulation in the sea pansy Renilla koellikeri. J Exp Biol 208: 2005-2017, 2005.
31. Das KC: Thioredoxin system in premature and newborn biology. Antioxid Redox Signal 6: 177-184, 2004.
32. Nalvarte I, Damdimopoulos AE and Spyrou G: Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Rad Biol Med 36: 1270-1278, 2004.
33. Liu R, Gao M, Yang ZH, et al: Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro.Brain Res 1216: 104-15, 2008.
34. Dohare P, Varma S and Ray M: Curcuma oil modulates the nitric oxide system response to cerebral ischemia/reperfusion injury.Nitric Oxide 19: 1-11, 2008.
35. Blomgren K, Hagberg H:Free radicals, mitochondria, and hypoxia-ischemia in the developing brain.Free Radic Biol Med 40:388-97,2006.
36. Han JD: The investigation of nerveprotective effect and mechanism of TongLuoHuaTan capsule and its active ingredient on cerebral ischemia reperfusion injury.Beijing University of Chinese Medicine.Doctoral dissertation. 2012.